Drug Type DNA aptamer |
Synonyms- |
Target |
Action inhibitors |
Mechanism IL-17A inhibitors(Interleukin 17A inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Axial Spondyloarthritis | Preclinical | Russia | 29 Jan 2026 | |
| Rheumatoid Arthritis | Preclinical | Russia | 29 Jan 2026 |





